We have the opportunity to achieve an AIDS-free generation, began Chip Lyons, President & CEO of the Elizabeth Glaser Pediatric AIDS Foundation. Despite diagnostics and treatment, children still lag behind adults in addressing the disease. Turning to the panelists, H.E. Khumbize Kandodo Chiponda, Malawi Minister of Health, noted that her country has come a long way to meet its targets around testing and treatment. Engaging with the community is a crucial way to meet people where they are and provide access to testing, prevention, and treatment. Helen McDowell, Head of Government & Global Public Health at ViiV Healthcare, highlighted how the pharmaceutical industry is working to create optimal tools in treating pediatric AIDS, including generics available to low- and middle-income and high-pediatric HIV burden countries, and long-acting products.
Dr. Philippe Duneton, Executive Director at UNITAID, explained how his organization is driven to make a difference to work in partnership with industry and governments. Industry is crucial for good products and access but ultimately it is about the people and communities affected by this disease. Building on the idea of how business can help, Dr. Christopher Austin MD, MSC, International Clinical Lead for Hospitals, Academic Medicine & Research Organizations at Amazon, described how Amazon Web Services is dedicated to healthcare initiatives that enable person-centered care, working collaboratively to make innovation more reachable and accessible. Dr. Harald Nusser, Vice President of Global Patient Solutions at Gilead Sciences, then spoke about how companies could use business innovation to end the HIV epidemic through collaboration instead of competition. Rounding out the panel, Dr. Mamadi Yilla, Deputy U.S. Global AIDS Coordinator for Multisector Relations at the U.S. Department of State, explained how PEPFAR hopes to bring change by introducing a new generation of partners to the fight and sparking new regional dialogue.
“This is not a ministry of health problem, it is not a government problem; it is our problem.”
H.E. Khumbize Kandodo Chiponda, Minister of Health, Government of Malawi
“If we want to talk about equity, what is a more inequitable situation than a kid who is suffering from AIDS and doesn’t have access to treatment?”
Dr. Philippe Duneton, Executive Director, UNITAID
“We have to think differently, we have to act differently. We need other kinds of innovation, we need other kinds of partnerships.”
Chip Lyons, President & CEO, Elizabeth Glaser Pediatric AIDS Foundation
“I think it’s a really exciting time for the industry to innovate around different options and choice for people with long-acting medicine.”
Helen McDowell, Head of Government & Global Public Health, ViiV Healthcare
“Person-centered care is really our focus and we do that by enabling organizations to innovate with our infrastructure.”
Dr. Christopher Austin MD, MSC, International Clinical Lead, Hospitals, Academic Medicine & Research Organizations, Amazon
“We have not been able to end the epidemic for everyone everywhere. We need to think about business model innovation because business is needed to end the epidemic.”
Dr. Harald Nusser, VP Global Patient Solutions, Gilead Sciences
“We are going to bring about change by introducing a new generation of partners.”
Dr. Mamadi Yilla, Deputy U.S. Global AIDS Coordinator for Multisector Relations, U.S. Department of State